Clinical Trials Logo

Clinical Trial Summary

Ascending aorta aneurysmal disease is common and can be complicated by dissection or rupture. There is substantial variation in individual aneurysm progression: established risk factors for an accelerated aneurysm growth rate include initial size or localization, the presence of aortic valve disease, congenital bicuspid aortic valve or connective tissue disorders.


Clinical Trial Description

Although there is an increased lifetime risk when the aortic diameter exceeds 6 cm, predicting aneurysm progression is nearly impossible and dissection and rupture also occur at diameters under 6 cm. The assessment of aortic hemodynamics and the presence of altered flow patterns, as well as distribution and changes in wall shear stress (WSS) and the oscillatory shear index (OSI), using 4D phase contrast cardiovascular magnetic resonance (CMR) may provide further insights in how aneurysms develop and in assessing the risk of dissection. The purpose of this study was to investigate in patients with dilated ascending aorta the flow patterns and vessel wall parameters in order to correlate these hemodynamics factors with changes in aorta size. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03172390
Study type Interventional
Source Centre Hospitalier Universitaire de Saint Etienne
Contact
Status Completed
Phase N/A
Start date October 11, 2017
Completion date March 4, 2020

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03414866 - Thoraflex Hybrid Post-Market Study
Completed NCT01632774 - Analysis of Risk Factors for Death After Blunt Traumatic Rupture of the Thoracic Aorta N/A
Recruiting NCT04937868 - Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
Recruiting NCT05065996 - Prediction of Aortic Dilatation and Rupture
Completed NCT02724072 - Thoraflex™ Hybrid IDE Study N/A
Not yet recruiting NCT04307888 - Spanish Percutaneous Aortic INtervention REGISTRY (SPAIN REGISTRY)